Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma

OBJECTIVE: Treatment of differentiated thyroid carcinoma (DTC) includes suppression of TSH with levothyroxine therapy, which may negatively influence bone mineral density (BMD), but the effects are controversial. We aimed to evaluate the relationship between TSH-suppressive therapy and BMD in postme...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Thyroid Res
Egile Nagusiak: de Melo, Thaís Gomes, da Assumpção, Lígia Vera Montalli, Santos, Allan de Oliveira, Zantut-Wittmann, Denise Engelbrecht
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474343/
https://ncbi.nlm.nih.gov/pubmed/26097507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-015-0019-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak